US 11279703
Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereof
granted A61KA61K31/498A61K31/519
Quick answer
US patent 11279703 (Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereof) held by APTOSE BIOSCIENCES INC. expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- APTOSE BIOSCIENCES INC.
- Grant date
- Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/498, A61K31/519, A61K45/06, A61P